Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001236927-25-000005

Director sold 46,808 shares at an average $355.31 ($16,631,386)

  • Director acquired 46,808 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FRIEDMAN PAUL A · Director

Table I: Non-derivative

14 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-11 Exercise or conversion : show line 1 in the form 10b5-1 +3,203 $9.45 $30,268 190,367 D
2025-08-11 Sale : show line 2 in the form 10b5-1 −2,903 $350.19 $1,016,605 187,464 D
2025-08-11 Sale : show line 3 in the form 10b5-1 −300 $351.04 $105,312 187,164 D
2025-08-12 Exercise or conversion : show line 4 in the form 10b5-1 +43,605 $9.45 $412,067 230,769 D
2025-08-12 Sale : show line 5 in the form 10b5-1 −3,303 $350.93 $1,159,113 227,466 D
2025-08-12 Sale : show line 6 in the form 10b5-1 −3,202 $351.59 $1,125,806 224,264 D
2025-08-12 Sale : show line 7 in the form 10b5-1 −1,382 $352.61 $487,309 222,882 D
2025-08-12 Sale : show line 8 in the form 10b5-1 −4,768 $354.06 $1,688,137 218,114 D
Open-market sales · 46,808 sh · avg $355.31 · $16,631,386

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-08-11 Exercise or conversion : show line 15 in the form 10b5-1 Stock Option (Right to Buy) −3,203 172,777 D
2025-08-12 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option (Right to Buy) −43,605 129,172 D
Loading xslF345X05/wk-form4_1755121546.xml…